#ThinkSabio US Market Morning Brief

Pre-Market Gainers:
$BCDA +114%: FDA approves CardiAMP® Heart Failure II protocol amendment for treatment screening (Aug 21).
$XTRX +51%: XORTX highlights research on genetic regulation of xanthine oxidase and purine metabolism targeting.
$BOF +26%: BranchOut Food projects $8 million in net revenue by year-end (Aug 28).
$AFRM +20%: Affirm GAAP EPS of -$0.14 beats estimate by $0.30; revenue of $659.18M beats by $53.8M (Aug 28).

Penny Gainers:
$BFI +12% No Recent News Found
$INVZ +11% No Recent News Found
$RVSN +11% No Recent News Found

Decliners:
$ABIO -49%: ARCA biopharma updates special dividend in merger with Oruka Therapeutics (Aug 26).
$AILE -41% No Recent News Found
$DG -23%: Dollar General Q2 2024 earnings miss estimates; EPS of $1.70 vs. $1.79 estimated.

Headlines:
$ASML: Netherlands may impose more curbs on ASML's China business, limiting repair and maintenance of semiconductor equipment.
$BBY: Best Buy reports non-GAAP EPS of $1.34, beating estimates by $0.18; revenue of $9.29B beats by $40M.
$X: Nippon Steel offers additional $1.3B investment in US Steel plants.